A new study published in the Journal of the American Heart Association on Wednesday, has concluded that breastfeeding is not only healthy for babies, but may also reduce a mother’s risk of having a heart attack or stroke later in life.
Around 1 in 6 older people experience some form of abuse, a figure higher than previously estimated and predicted to rise as populations age worldwide.
A recent report by the World Health Organisation, WHO, has revealed that Ekiti and Zamfara has the highest rate of HIV prevalence among States in Nigeria in 2017. The ranking in the latest list illustrate a change in positions as the virus continue to spread across the country.
...what we used to know as far as meningitis is concerned is that, its a Type A virus...
Researchers have unveiled a groundbreaking wearable device that continuously monitors the heart and lungs of hospital patients as they rest, presenting a transformative alternative to traditional CT scans. Developed by scientists at the University of Bath in partnership with Polish tech firm Netrix, the innovative belt-like device wraps around the chest and uses ultrasound technology to produce high-resolution, real-time images of internal organs. Unlike CT scans that provide a single snapshot, this device delivers a dynamic stream of images over extended periods, offering clinicians a more comprehensive view of a patient’s health.
A major new study suggests that weight-loss injections could nearly halve the risk of cancers linked to obesity. Cancer specialists have hailed the research as “groundbreaking,” with the potential to usher in a “new era of preventive cancer medicine.” Obesity has been linked to 13 different types of cancer. Although losing weight is already known to lower cancer risk, scientists have found that weight-loss drugs offer additional protective benefits beyond simply reducing body weight. Researchers in Israel tracked 6,000 adults without a prior history of cancer, who either underwent bariatric surgery or used glucagon-like peptide-1 receptor agonists (GLP-1RAs) such as liraglutide (Saxenda), exenatide (Byetta), or dulaglutide (Trulicity). These medications mimic the GLP-1 hormone, helping lower blood sugar and increasing feelings of fullness.
